## Insulin Deficiency and Unopposed Glucagon in DKA ### The Central Pathophysiology of DKA **Key Point:** DKA is fundamentally a state of **severe insulin deficiency** combined with **relative or absolute glucagon excess**. The hyperglycemia and ketosis result not from glucagon resistance, but from the unopposed metabolic actions of glucagon in the absence of insulin's restraining effects. ### Insulin–Glucagon Axis in DKA | Parameter | Normal Fasting | DKA | |-----------|----------------|-----| | **Insulin** | 5–15 mIU/mL | <2 mIU/mL (severe deficiency) | | **Glucagon** | 50–100 pg/mL | 800–1500 pg/mL (elevated) | | **Insulin:Glucagon Ratio** | ~0.1 (insulin dominant) | <0.01 (glucagon dominant) | | **Blood Glucose** | 70–100 mg/dL | >250 mg/dL | | **Ketone Bodies** | <1 mmol/L | >5 mmol/L | ### Mechanism: Why High Glucagon Causes Hyperglycemia and Ketosis Without Insulin 1. **Loss of Insulin's Inhibitory Effects on Glucagon** - Insulin normally suppresses glucagon secretion via paracrine inhibition and direct effects on alpha cells - In type 1 DM, beta cell destruction → no insulin → alpha cells are disinhibited → glucagon rises 2. **Unopposed Glucagon Action on Hepatic Glucose Production** - Glucagon stimulates hepatic glycogenolysis and gluconeogenesis via cAMP → PKA activation - **Without insulin**, there is no opposing signal to suppress these pathways - Insulin normally antagonizes glucagon by: - Inhibiting hormone-sensitive lipase (HSL) → reducing lipolysis - Inhibiting glycogenolysis - Promoting glycogen synthesis - Result: **Uncontrolled hepatic glucose output** → hyperglycemia 3. **Unopposed Lipolysis and Ketogenesis** - Glucagon activates HSL → massive lipolysis → free fatty acids (FFAs) flood the liver - **Without insulin**, malonyl-CoA (the inhibitor of CPT-1) is low → FFAs freely enter mitochondria - β-oxidation → excess acetyl-CoA → ketone body production (acetoacetate, β-hydroxybutyrate) - Result: **Severe metabolic acidosis** from ketone accumulation ```mermaid flowchart TD A[Type 1 DM: Beta Cell Destruction]:::outcome --> B[Severe Insulin Deficiency]:::outcome B --> C[Loss of Insulin Inhibition on Alpha Cells]:::action C --> D[Glucagon Rises]:::outcome D --> E[Unopposed Glucagon Action]:::decision E -->|Liver| F[Glycogenolysis + Gluconeogenesis]:::action E -->|Adipose| G[Lipolysis via HSL]:::action F --> H[Hyperglycemia]:::urgent G --> I[Excess FFA to Liver]:::action I --> J[β-oxidation → Ketones]:::action J --> K[Metabolic Acidosis]:::urgent B --> L[No Insulin to Suppress Glucagon]:::action L --> M[Unopposed Metabolic Actions]:::decision ``` **Clinical Pearl:** The **insulin:glucagon ratio** is the master regulator of fed vs. fasted metabolism. In DKA, this ratio inverts catastrophically—glucagon becomes the dominant hormone. The elevated glucagon is *appropriate* for fasting but *pathological* in the absence of insulin to counterbalance it. **High-Yield:** **Glucagon is NOT resistant in DKA**—it is highly effective, but unopposed. Insulin therapy rapidly suppresses glucagon secretion and restores the normal insulin:glucagon ratio, halting ketogenesis and hyperglycemia. ### Why the Elevated Glucagon Is Appropriate (Not Pathological) The alpha cell is responding correctly to the perceived "fasting state" (low insulin, high glucose). The problem is not glucagon excess per se, but the **absence of insulin to restrain it**. [cite:Ganong's Review of Medical Physiology 26e Ch 19; Harrison's Principles of Internal Medicine 21e Ch 417]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.